Background

The Advanced Practice Pharmacist (APh) licensure has provided an opportunity for pharmacists to expand their scope of practice in California; however, there have not been any studies in California assessing the interventions made by APhs as credentialed providers of care.

Objective

To assess the clinical interventions made by APhs as credentialed providers with clinical privileges in an independent community pharmacy.

Methods

This was a retrospective, observational study that assessed clinical interventions made by APhs on patients referred for disease state management between January 2018 and December 2018. Pharmacist interventions were stratified into 3 levels of provider care: full privilege (FP), limited privilege (LP), and no privilege.

Results

FP had the highest percentage of accepted recommendations (62.2% ± 20.1%), whereas LP and no privilege had lower percentages of accepted recommendations (41.9% ± 12.0% and 31.6% ± 3.7%, respectively) (P < 0.01).

Conclusion

APhs as credentialed providers with FP, or even LP, made more successful clinical interventions than those without any privileges.

中文翻译：

---

资格证书和提供者特权对加利福尼亚高级实践药师进行的临床干预的影响。

背景

高级执业药师（APh）许可证为药剂师提供了扩展在加利福尼亚州执业范围的机会；但是，在加利福尼亚州，尚无任何研究评估APhs作为合格的护理提供者的干预措施。

目的

评估APhs作为独立社区药房中具有临床特权的合格提供者进行的临床干预。

方法

这是一项回顾性观察性研究，评估了APhs在2018年1月至2018年12月之间对转介疾病状态管理患者的临床干预措施。药剂师的干预措施分为三个级别的提供者护理：完全特权（FP），有限特权（LP） ，并且没有特权。

结果

FP接受建议的百分比最高（62.2％±20.1％），而LP和无特权的接受建议的百分比较低（分别为41.9％±12.0％和31.6％±3.7％）（P <0.01）。

结论

APhs作为具有FP甚至LP认证的提供者，比没有特权的提供更好的临床干预。